Bjarne Due Larsen

Bjarne Due Larsen has a diverse work experience in the pharmaceutical industry and academia. Bjarne Due joined Zealand Pharma in 1998 and held various roles such as Head of Medicinal Chemistry and Head of Innovation, Chemistry. Larsen also worked at the University of Copenhagen as an associate professor. In 2011, they became the CEO of Dalides, and later returned to Zealand Pharma, where they served as the VP of Chemistry and Head of Gap Junction Innovation. Throughout their career, Larsen demonstrated expertise in chemistry, innovation, and external scouting.

Bjarne Due Larsen earned a Ph.D in Peptide Chemistry from the University of Copenhagen in 1991. Prior to this, they attended the University of Copenhagen from 1978 to 1986, but no specific degree or field of study was provided.